Le Lézard
Classified in: Health
Subjects: CCA, ACC

Invitation to presentation of RaySearch's interim report for the second quarter of 2023


STOCKHOLM, Aug. 8, 2023 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the second quarter of 2023 on August 25, 2023, at 10.00 am CEST. The report will be published on August 25, 2023, at 07.45 am and will be available together with presentation slides on raysearchlabs.com. Johan Löf, founder and CEO, and Annika Blondeau Henriksson, interim CFO, will present the company's development in a webcast. After the presentation (held in English) there is the opportunity to ask questions.

Link to webcast: https://raysearchlabs.creo.se/230825/

Or dial in to join the webcast:
Sweden: +46 (0) 8 5051 0031
United Kingdom: +44 (0) 207 107 06 13
United States: +1 (1) 631 570 56 13

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]

Annika Blondeau Henriksson, interim CFO, RaySearch Laboratories AB (publ) 
Telephone: +46 (0) 8 510 530 00
[email protected]

The following files are available for download:

https://mb.cision.com/Main/1102/3814732/2218376.pdf

RaySearch Press Release August 8, 2023

 

SOURCE RaySearch Laboratories


These press releases may also interest you

at 08:00
Organon ("Organon"), a global healthcare company with a focus on women's health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the "Co-Issuer" and, together...

at 08:00
Sirona Biochem Corp. has announced a partnership with Stonegate Healthcare Partners. Stonegate is a leading corporate advisory firm based in Dallas, Texas that offers research driven business development and investor outreach services. Leveraging...

at 07:45
Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced results for the first quarter 2024. In a concurrent press release accompanying Agenus' earnings announcement, a $100M...

at 07:45
Crescent Innovations Inc. announced today the sale of its technology related to bone regeneration, plus various intellectual property and know-how assets. Chris Finn, President of the advisory firm Alternotio announced today that Crescent Innovations...

at 07:40
One year since forming its Advisory Board, Lokavant, the clinical trial intelligence platform company, announces three new members, including Pfizer's Head of Predictive Analytics Jonathan Crowther. The Lokavant Advisory Board brings together...

at 07:39
Lucid Diagnostics Inc.  ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc....



News published on and distributed by: